Today: 1 May 2026
Meta stock slips after-hours as scam-ad scrutiny mounts, Manus AI deal draws focus
31 December 2025
2 mins read

Meta stock slips after-hours as scam-ad scrutiny mounts, Manus AI deal draws focus

NEW YORK, December 31, 2025, 4:35 PM ET — After-hours

Meta Platforms (META) shares slipped about 0.9% in after-hours trading on Wednesday, hovering near $660. The Facebook and Instagram owner traded between $659.35 and $667.08 in the session.

The year-end move comes as investors weigh two forces that can pull in opposite directions: Meta’s push to add new AI features and the risk that tougher fraud rules raise costs or slow ad sales. With liquidity thinning into holidays, company-specific headlines can have an outsized impact.

Meta still relies on advertising for the bulk of its revenue, which makes brand safety and platform trust immediate market issues. At the same time, AI spending and deal-making can reshape the growth story, but they also put pressure on margins if costs rise faster than sales.

A Reuters investigation published on Wednesday said internal documents show Meta built a “playbook” aimed at delaying “universal advertiser verification” — identity checks for all advertisers — as governments pushed for tougher controls on scam ads. The report also described how Meta studied searches of its public Ad Library and adjusted enforcement so problematic ads were less discoverable to regulators, journalists and investigators; it noted Alphabet’s Google has said it has verified more than 90% of advertisers. Reuters

In a separate development late Tuesday, the U.S. Virgin Islands sued Meta, alleging the company profited from advertisements for scams and failed to keep its platforms safe for children. Meta has denied the allegations and said user reports of scams on its platforms have fallen over the last 18 months, Reuters reported.

Meta said on Monday it would acquire Chinese-founded AI startup Manus and integrate its technology into products including Meta AI, with a source putting the deal value at $2 billion to $3 billion. Rosenblatt Securities analyst Barton Crockett called the deal “a natural fit into Meta’s fast-growing WhatsApp SMB footprint.” Reuters

SMB refers to small and medium-sized businesses, a segment where WhatsApp has become a major channel for customer support and sales chats. Manus has marketed itself as a “general AI agent,” meaning software designed to take actions with less step-by-step prompting than a standard chatbot.

The broader market backdrop was cautious: Wall Street closed the final session of 2025 lower, with the S&P 500 down 0.73% and the Nasdaq down 0.76%. U.S. markets are closed on Thursday for New Year’s Day.

For Meta, investors now have two near-term watchpoints: whether the Manus deal draws extra scrutiny because of its China ties, and whether policymakers respond to the latest reporting on scam ads with new verification requirements. Either outcome could change the company’s cost profile and regulatory risk heading into 2026.

The trade-off is straightforward. New AI products can support engagement and open up new business tools over time, but compliance costs and litigation can move faster than product cycles.

Meta’s shares have tended to track the broader megacap tech group this year, but the latest headlines are company-specific. That keeps attention on what Meta says next about spending, safety measures and how quickly it can fold new AI capabilities into consumer and business products.

Meta stock held around $660 into the after-hours session. With trading resuming Friday, investors will be watching for follow-through on the Manus acquisition and any new legal or regulatory signals tied to scam advertising.

Stock Market Today

  • Cocoa Prices Rise on Strong Chocolate Demand and Supply Concerns
    May 1, 2026, 1:54 PM EDT. Cocoa prices are climbing, with July ICE London cocoa hitting a 2.5-month high, supported by steady consumer demand for chocolate and smaller global surplus forecasts. Top chocolate makers Hershey and Mondelez reported better-than-expected earnings, indicating resilient demand despite high prices. StoneX lowered its global surplus outlook due to possible crop risks from El Niño, while disruptions from the Strait of Hormuz closure are increasing costs for cocoa importers. However, weak cocoa grindings in North America and Europe and declining chocolate sales pose downward pressure. Current cocoa supplies remain abundant, notably with a 20-month high in ICE inventories, though stable shipments from Ivory Coast and declining Nigerian exports add complexity to the market outlook.

Latest article

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

1 May 2026
The Dow Jones Industrial Average fell 78.72 points to 49,573.42 by midday Friday, reversing an early rally as tariff concerns weighed on gains from Apple and other strong earnings reports. President Donald Trump announced a 25% tariff on EU-made cars and trucks starting next week. Apple reported quarterly revenue of $111.2 billion, up 17% year over year. Oil prices dropped after Iran sent a new negotiation proposal.
US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

1 May 2026
The S&P 500 rose 0.48% and the Nasdaq 0.96% to record highs Friday, while the Dow slipped 0.11%. Apple shares climbed after reporting its strongest quarterly sales growth in over four years. Atlassian and other software stocks rallied on strong cloud demand. Exxon and Chevron beat profit estimates but cited pressure from Middle East conflict and volatile oil prices.
Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

1 May 2026
Recursion Pharmaceuticals said founder and board chair Chris Gibson will not seek re-election at the June 17 annual meeting, months after stepping down as CEO. The company reports first-quarter results May 6, with investors watching for updates on cash, clinical progress, and its AI drug platform. Recursion last reported $753.9 million in cash and narrowed its quarterly net loss. Gibson will remain chair until his term ends.
Broadcom stock (AVGO) slips after hours as SEC filing flags insider sale
Previous Story

Broadcom stock (AVGO) slips after hours as SEC filing flags insider sale

Robinhood stock slips into year-end after December trading snapshot; Barclays flags Q4 risk
Next Story

Robinhood stock slips into year-end after December trading snapshot; Barclays flags Q4 risk

Go toTop